Josephine Forbes

Last updated

Josephine Forbes
Professor Josephine Forbes.jpg
Nationality Australian
Alma mater University of Melbourne
AwardsCommonwealth Health Minister's Award
Young Tall Poppy Award
NHMRC Achievement Award
Scientific career
Fields Medicine
Diabetes
Nephrology
Institutions Mater Research

Josephine Forbes (born 20 August 1970) is an Australian scientist specialising in the study of glycation and diabetes. She has been studying diabetes since 1999 and has worked at Royal Children's Hospital, University of Melbourne and Baker Heart and Diabetes Institute in Melbourne Australia. Since 2012 she has led the Glycation and Diabetes team at Mater Research which is a world-class medical research institute based at South Brisbane, and part of the Mater Group. Josephine is program leader for Mater's Chronic Disease Biology and Care theme, building greater understanding of the biological basis of a broad range of chronic diseases, and developing preventative strategies and innovative treatments to improve patient outcomes. Josephine and her team focus on how advanced glycation contributes to the pathogenesis of diabetes and its complications such as kidney disease. [1]

Contents

Biography

Professor Forbes currently leads a team of post-doctoral researchers and supervises numerous students, in addition to being a professor of medicine at the University of Queensland and a principal research fellow in the Department of Medicine at the University of Melbourne. [2]

Education

Forbes was awarded her PhD in Nephrology in 1999 from the University of Melbourne, for research carried out at the Royal Children's Hospital. She is currently an NHMRC Senior Research Fellow and has held research grants from the NHMRC of Australia, the Juvenile Diabetes Research Foundation (JDRF) and the National Institutes of Health (USA). [1]

Awards

Forbes has received many awards in recognition of her research:

Research

Forbes' research focuses on the process of advanced glycation and its contribution to diabetes and its complications, in particular kidney disease. Her recent work includes research into how advanced glycation of food by modern processing techniques and storage may be contributing to our diabetes epidemic. [2]

Her research aims to find medicines which reduce the accumulation of products of advanced glycation, which in turn will impact the incidence of diabetes and kidney disease. Her research also aims to provide information to food regulatory authorities and health care providers about advanced glycation in food and the implications of ingesting this in excess. [4]

So far this research has identified a class of medicines which appears to be effective for the treatment of kidney disease in diabetes, and also affects how our bodies process sugar. In the food area, she has conducted a clinical trial in overweight individuals examining the effects of advanced glycation products in food on their sugar handling and kidney function. Her team is also part of a large clinical trial tracking the consumption of advanced glycation products by mothers and their babies to see if there is an association with this and the development of Type 1 diabetes in later life. [4]

Her work to date has resulted in more than 100 publications with more than 4500 citations.

Fellowships

Related Research Articles

<span class="mw-page-title-main">Nephrology</span> Medical study concerned with the kidneys

Nephrology is a specialty of adult internal medicine and pediatric medicine that concerns the study of the kidneys, specifically normal kidney function and kidney disease, the preservation of kidney health, and the treatment of kidney disease, from diet and medication to renal replacement therapy. The word "renal" is an adjective meaning "relating to the kidneys", and its roots are French or late Latin. Whereas according to some opinions, "renal" and "nephro" should be replaced with "kidney" in scientific writings such as "kidney medicine" or "kidney replacement therapy", other experts have advocated preserving the use of renal and nephro as appropriate including in "nephrology" and "renal replacement therapy", respectively.

Hugh Redmond Brady is an Irish academic, the 17th President of Imperial College London, and a professor of medicine. He was the 13th President and Vice-Chancellor of the University of Bristol. He is also President Emeritus of University College, Dublin (UCD), having served as UCD's eighth President from 2004 to 2013.

Priscilla Sheath Kincaid-Smith, Mrs. Fairley, AC, CBE, was an Australia-based South African physician and researcher, specializing in nephrology. She was a past President of the Royal Australasian College of Physicians, World Medical Association and International Society of Nephrology (1972–75).

Michael Cowley FTSE is an Australian physiologist. He is best known for his mapping of the neural circuits involved in metabolism and obesity and diabetes treatment. He is a professor in the Department of Physiology at Monash University in the Faculty of Biomedical and Psychological Sciences. He is also a director of the Australian diabetes drug development company, Verva Inc, and director of the Monash Obesity & Diabetes Institute] (modi).

<span class="mw-page-title-main">Brendan Crabb</span> Australian scientist (born 1966)

Brendan Scott CrabbFASM is an Australian microbiologist, research scientist and director and chief executive officer of the Burnet Institute, based in Melbourne, Victoria, Australia.

Karin M. Hehenberger is a Swedish physician, investor, business executive, and diabetes expert, known for her work in the field of biotechnology. She has written numerous articles on biotechnology that have been published in peer review journals and worked as an executive for different biotechnology companies and investment firms. She is a faculty member in the department of Molecular Medicine at the Karolinska Institute where she also obtained her M.D. and a Ph.D. in molecular medicine. She has lectured on the topics of autoimmune diseases, diabetes, molecular medicine and industry challenges as well as provided commentary for Fox News, Good Morning America Health, New York One, the USA Today and Forbes.

<span class="mw-page-title-main">ENDIA</span>

The Environmental Determinants of Islet Autoimmunity (ENDIA) Study is an Australian prospective pregnancy cohort study investigating the environmental triggers responsible for the autoimmune process that leads to type 1 diabetes. The study is led by Professor Jennifer Couper from the University of Adelaide in South Australia with collaborators from the Walter and Eliza Hall Institute, Royal Melbourne Hospital, Monash University and Monash Medical Centre in Victoria, the University of NSW and the Children's Hospital at Westmead, the Royal Hospital for Women and St. George's Hospital in NSW, the University of Queensland and Mater Health Services in Queensland, and the University of Western Australia and Princess Margaret Hospital for Children in Western Australia.

Amanda Jane Fosang is a biomedical researcher who has pioneered arthritis research in Australia.

<span class="mw-page-title-main">Translational Research Institute (Australia)</span>

The Translational Research Institute (TRI) is Australia's first translational medical research institute dedicated to translating scientific discoveries into applications for medical practice.

<span class="mw-page-title-main">Josephine Briggs</span> American nephrologist

Josephine P. Briggs is an American nephrologist and director emeritus of the National Center for Complementary and Integrative Health, an agency of the National Institutes of Health. She is currently the editor-in-chief of the Journal of the American Society of Nephrology.

Vlado Perkovic is an Australian renal physician and researcher who is the Provost at the University of New South Wales, Sydney, having previously been Dean of Medicine & Health at that University between 2019 and 2023.

Professor David Wayne Johnson is an Australian nephrologist known for kidney treatments and transplants in Australia. In 2009 he was a Queensland State Finalist for Australian of the Year, for his work in the early recognition and care of people with chronic kidney disease and specifically for his work in detection of chronic kidney disease.

<span class="mw-page-title-main">Melissa Little</span> Australian scientist and academic (born 1963)

Melissa Helen Little is an Australian scientist and academic, currently Theme Director of Cell Biology, heading up the Kidney Regeneration laboratory at the Murdoch Children's Research Institute. She is also a Professor in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Program Leader of Stem Cells Australia. In January 2022, she became CEO of the Novo Nordisk Foundation Center for Stem Cell Medicine reNEW, an international stem cell research center based at University of Copenhagen, and a collaboration between the University of Copenhagen, Denmark, Murdoch Children’s Research Institute, Australia, and Leiden University Medical Center, The Netherlands.

Alan Frederick Cowman AC, FRS, FAA, CorrFRSE, FAAHMS, FASP, FASM is an internationally acclaimed malaria researcher whose work specialises in researching the malaria-causing parasite, Plasmodium falciparum, and the molecular mechanisms it uses to evade host responses and antimalarial drugs. He is currently deputy directory of the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne, and his laboratory continues to work on understanding how Plasmodium falciparum, infects humans and causes disease. He was elected as a fellow of the Royal Society in 2011 and awarded the Companion of the Order of Australia in 2019 for his "eminent service to the biological sciences, notably to molecular parasitology, to medical research and scientific education, and as a mentor."

Professor Wendy Elizabeth Hoy AO is a Fellow of the Australian Academy of Science (FAA), the Director of the Centre for Chronic Disease at the University of Queensland, Australia, and was appointed an Officer of the Order of Australia (AO) in 2010 and elected as a member of the Australian Academy of Science in 2015. Hoy's research has involved developing new types of kidney imaging and improving health and lives for indigenous populations, in Australia, Sri Lanka and the USA.

Louise Maple-Brown is an Australian endocrinologist. She is a clinical researcher at the Royal Darwin Hospital, serving as the hospital's Head of Endocrinology and as NHMRC Practitioner Fellow with the Menzies School of Health Research at Charles Darwin University. She leads a clinical research program within the Wellbeing and Preventable Chronic Diseases division of Menzies with a focus on diabetes in Indigenous Australians and provides clinical diabetes services to urban and remote Northern Territory communities.

<span class="mw-page-title-main">Emily Banks</span> Epidemiologist and public health researcher

Emily Banks is an Australian epidemiologist and public health physician, working mainly on chronic disease. She is a Professor of Epidemiology and Public Health and Head of the Centre for Public Health Data and Policy at the Australian National University, and a visiting professor at the University of Oxford.

Adeera Levin MD, FRCPC is a Professor of Medicine, and is head of the Division of Nephrology at University of British Columbia.

Associate Professor Asha Bowen is an Australian Paediatric Infectious Diseases clinician-scientist and a leading voice and advocate for children's health and well-being. She is Head of the Department of Infectious Diseases at Perth Children's Hospital, Head of the Healthy Skin and ARF Prevention team and Program Head of the End Rheumatic Heart Disease program at the Telethon Kids Institute. Bowen leads a large body of skin health research in partnership with healthcare workers and community in the Kimberley while expanding her team and work to understand skin health in urban Aboriginal children better. She has been widely acknowledged and awarded for her contributions towards improving the health and well-being of Australian children, and addressing existing health inequities faced by First Nations Australian children and their families. Throughout the COVID-19 pandemic she contributed her knowledge and expertise to clinical research, guideline development and on several national committees. She has published widely in the area of paediatric infectious diseases and is a recognized expert in the field who regularly contributes to popular Australian media sources such as The Conversation.

Deidra C. Crews MD, ScM is an American nephrologist and epidemiologist. She is the Deputy Director of Johns Hopkins Center for Health Equity and a Professor of Medicine at Johns Hopkins School of Medicine. Crews research focuses on social drivers of disparities in kidney disease and hypertension.

References

  1. 1 2 "Professor Josephine Forbes".
  2. 1 2 "Josephine Forbes". The Conversation. Retrieved 7 August 2014.
  3. "2008 Victorian Award Winners". www.aips.net.au/. Australian Institute of Policy and Science. Retrieved 7 August 2014.
  4. 1 2 3 "Josephine Forbes". National Health and Medical Research Council . Retrieved 7 August 2014.
  5. "Australia's best and brightest researchers recognised in 2010 NHMRC Excellence Awards". www.nhmrc.gov.au. Australian Government National Health and Medical Research Council. Archived from the original on 14 August 2014. Retrieved 7 August 2014.
  6. "Women in Technology Announce Their 2014 WiT Award Winners" (PDF).